A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

NCT00109707 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

507

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myelogenous Leukemia
Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
Hypereosinophilic Syndrome
Systemic Mastocytosis

Interventions

DRUG: Nilotinib

Sponsor

Novartis Pharmaceuticals